merged_cord-blood-storage-contamination.txt
<question_number>1</question_number>
<answer>Private cord blood banks misleadingly market the potential future utility of stored stem cells, despite the low likelihood of their use, by touting the cells' "lifesaving possibilities" and claiming they can be used to treat over 80 different conditions.</answer>

<question_number>2</question_number>
<answer>Cord blood bank sales representatives are largely exempt from the strict laws prohibiting kickbacks to doctors that apply to pharmaceutical and medical device industries, because insurers do not cover their product.</answer>

<question_number>3</question_number>
<answer>FDA inspectors found that CBR failed to ensure "appropriate shipping conditions" for cord blood samples, leading to multiple cases where the stem cells arrived warmer than the accepted threshold, which could have contributed to bacterial growth.</answer>

<question_number>4</question_number>
<answer>CBR's marketing claim, as highlighted in their campaign with Chrissy Teigen, that cord blood stem cells "can be used to treat over 80 different conditions" is misleading based on the actual scientific evidence presented in the article.</answer>

<question_number>5</question_number>
<answer>Anna Lazos's case illustrates the potential pitfalls of relying on private cord blood banks, as her son's cord blood sample was found to be contaminated with E. coli and unusable for a clinical trial, despite her having paid thousands of dollars to store it.</answer>

<question_number>6</question_number>
<answer>Chrissy Teigen was the celebrity endorser of cord blood banking featured in a CBR campaign that generated over $6 million in revenue.</answer>

<question_number>7</question_number>
<answer>CBR was the cord blood bank that faced FDA scrutiny for bacterial growth in its processing area, despite marketing its services as a "biological insurance policy".</answer>

<question_number>8</question_number>
<answer>CooperSurgical, which owns CBR, was the cord blood bank's parent company that was acquired for $1.6 billion, with two-thirds of its value attributed to umbilical cord storage.</answer>

<question_number>9</question_number>
<answer>CBR was the cord blood bank that started a program offering free banking to families wanting to enroll older children in clinical trials, despite quality control issues at its facility.</answer>

<question_number>10</question_number>
<answer>ViaCord was the cord blood bank that continued charging a customer for two years after discovering bacterial contamination in their sample without informing them.</answer>